Peloton Therapeutics' Series A Round

Peloton Therapeutics raised a round of funding on July 14, 2011.

Peloton Therapeutics is a clinical-stage biotechnology company that discovers and develops first-in-class, small molecule cancer therapies targeting unexploited molecular vulnerabilities. Peloton Ther…

Articles about Peloton Therapeutics' Series A Round: